Advisers Favor FDA Contraindicating Specific ESI Technique, Formulation
Wed, 26 Nov 2014 00:00:00 -0500
For the safety of patients, FDA should contraindicate the transforaminal route of delivery of corticosteroid suspensions to the epidural space, a group of agency advisers decided on Tuesday.
New Internet Domain Launching for Pharmacy Community
Tue, 25 Nov 2014 00:00:00 -0500
With its launch
of a new family of Internet domain names, the National
Association of Boards of Pharmacy (NABP) hopes to establish a safe place within
cyberspace for consumers to purchase and get facts about medications.
Emergency Physicians Group Supports ED Clinical Pharmacy Services
The nation’s largest professional organization of emergency medicine physicians decided at its recent annual meeting to create a policy statement that supports clinical pharmacists as a part of the emergency medicine team.
PML Death Reported in Patient Treated With Dimethyl Fumarate
FDA today announced
upcoming changes to the labeling of dimethyl fumarate after the death of the
patient who was taking the drug for the treatment of multiple sclerosis (MS).
Company Recalls NorthStar Rx's Gabapentin 300-mg Capsules
Some of the 300-mg gabapentin capsules in lot GESB14011-A from NorthStar Rx LLC may be empty, according to a notice circulated Monday by FDA on behalf of the U.S. subsidiary of the overseas manufacturer.